{"id":"W2561344970","doi":"10.1182/blood.v110.11.2042.2042","title":"A Phase II Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Neutropenia; Internal medicine; Tumor lysis syndrome; Gastroenterology; Chronic lymphocytic leukemia; Rituximab; Febrile neutropenia; Immunology; Surgery; Multiple myeloma; Leukemia; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002171114,0.001751087,0.002086809,0.0005553127,0.0006371945,0.001016088,0.001214015,0.001724372,0.003883598],"category_scores_gemma":[0.0007974218,0.0007006897,0.00103595,0.0005019342,0.001012868,0.000902337,0.0005116764,0.003031544,0.001311175],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001022191,"about_ca_system_score_gemma":0.001938569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001253004,"about_ca_topic_score_gemma":0.003058339,"domain_scores_codex":[0.9993647,0.0003130458,0.00004306945,0.00009349365,0.00006424683,0.0001214807],"domain_scores_gemma":[0.9990624,0.0001076254,0.0001245591,0.00007992535,0.00005461956,0.0005709075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5833574,0.2008221,0.01502418,0.001145558,0.001151189,0.00107666,0.0006809431,0.001766887,0.07710103,0.0003816584,0.005548627,0.1119438],"study_design_scores_gemma":[0.4668829,0.5093074,0.01481107,0.0000426888,0.0002491067,0.0005585744,0.0001054391,0.0005829106,0.00359597,0.0001749461,0.003665557,0.00002334983],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872887,0.002020651,0.000718064,0.0006537286,0.0001976579,0.005617139,0.001187799,0.000118642,0.002197679],"genre_scores_gemma":[0.9803219,0.002120354,0.002144749,0.001519339,0.00026314,0.005570887,0.003934608,0.00004108719,0.004083915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003883598,"threshold_uncertainty_score":0.01299196,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01871685591115081,"score_gpt":0.325668133740166,"score_spread":0.3069512778290152,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}